SEELOS THERAPEUTICS, INC. — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$2.2M

Net Income/Loss (FY2023)

-$37.9M

Total Assets (FY2023)

$5.4M

Total Equity (FY2023)

-$33.5M

Cash Flows from Operating Activities (FY2023)

-$23.9M

Source: SEELOS THERAPEUTICS, INC. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.